These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22964613

  • 21. B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules.
    Bentz BG, Miller BT, Holden JA, Rowe LR, Bentz JS.
    Otolaryngol Head Neck Surg; 2009 May; 140(5):709-14. PubMed ID: 19393416
    [Abstract] [Full Text] [Related]

  • 22. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 23. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
    Koh J, Choi JR, Han KH, Kim EK, Yoon JH, Moon HJ, Kwak JY.
    PLoS One; 2013 Mar; 8(5):e64505. PubMed ID: 23717622
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 28. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 29. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.
    Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV.
    Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 32. Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients.
    Kleiman DA, Sporn MJ, Beninato T, Crowley MJ, Nguyen A, Uccelli A, Scognamiglio T, Zarnegar R, Fahey TJ.
    Cancer; 2013 Apr 15; 119(8):1495-502. PubMed ID: 23280049
    [Abstract] [Full Text] [Related]

  • 33. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for diagnosis of thyroid nodules: The influence of false-positive and false-negative results.
    Zhao CK, Zheng JY, Sun LP, Xu RY, Wei Q, Xu HX.
    Cancer Med; 2019 Sep 15; 8(12):5577-5589. PubMed ID: 31397092
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison Between Real-Time PCR and Pyrosequencing for Detection of BRAF V600E Mutation in Thyroid Fine-Needle Aspirates.
    Kim WY, Kim H, Hwang TS, Oh SY.
    Appl Immunohistochem Mol Morphol; 2017 Sep 15; 25(5):358-365. PubMed ID: 26657877
    [Abstract] [Full Text] [Related]

  • 36. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D, Yu X, Li H, Zhang M, Chen J.
    Medicine (Baltimore); 2021 Sep 17; 100(37):e27167. PubMed ID: 34664843
    [Abstract] [Full Text] [Related]

  • 37. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
    Zhang YZ, Xu T, Cui D, Li X, Yao Q, Gong HY, Liu XY, Chen HH, Jiang L, Ye XH, Zhang ZH, Shen MP, Duan Y, Yang T, Wu XH.
    Sci Rep; 2015 Nov 24; 5():16927. PubMed ID: 26597052
    [Abstract] [Full Text] [Related]

  • 38. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
    Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.
    Clin Endocrinol (Oxf); 2007 May 24; 66(5):678-83. PubMed ID: 17381488
    [Abstract] [Full Text] [Related]

  • 39. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.
    Troncone G, Cozzolino I, Fedele M, Malapelle U, Palombini L.
    Diagn Cytopathol; 2010 Mar 24; 38(3):172-6. PubMed ID: 19693938
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.